Disease Markers

Table of Contents

  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 6248264
  • - Research Article

Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect

Mohamed Haddad | Ines Knani | ... | Mohsen Kerkeni
  • Disease Markers -
  • Special Issue
  • - Volume 2016
  • - Article ID 9602472
  • - Review Article

Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma

Alexandra Ion | Iris Maria Popa | ... | Daniel Boda
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 4703854
  • - Research Article

RANTES Gene Polymorphisms Associated with HIV-1 Infections in Kenyan Population

Shem P. M. Mutuiri | Helen L. Kutima | ... | Samoel A. Khamadi
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 8246839
  • - Research Article

Redox Status of β2GPI in Different Stages of Diabetic Angiopathy

Jun Ma | Jing-Yun Zhang | ... | Pei Yu
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 1701637
  • - Research Article

Overexpression of Prolyl-4-Hydroxylase-α1 Stabilizes but Increases Shear Stress-Induced Atherosclerotic Plaque in Apolipoprotein E-Deficient Mice

Xiao-qing Cao | Xin-xin Liu | ... | Mei Zhang
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7531472
  • - Research Article

The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience

Jarosław Dybko | Bożena Jaźwiec | ... | Kazimierz Kuliczkowski
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7040312
  • - Research Article

Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I

Hanan A. Assaf | Wafaa M. Abdel-Maged | ... | Soher A. Ali
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 3650909
  • - Research Article

Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study

Michaela Neprasova | Dita Maixnerova | ... | Petr Kacer
  • Disease Markers -
  • Special Issue
  • - Volume 2016
  • - Article ID 2425091
  • - Editorial

Diagnostic and Prognostic Markers in Bladder Cancer

Ja Hyeon Ku | Wun-Jae Kim | ... | Luis Alex Kluth
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7068986
  • - Research Article

miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells

Junjie Niu | Yibao Sun | ... | Bo Liu
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 8376979
  • - Research Article

Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins

Stephanie Seneff | Nancy L. Swanson | ... | Chen Li
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 7484516
  • - Research Article

KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer

Shu Zhang | Fang Huang | ... | Han Wu
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 1532791
  • - Research Article

Dynamics of SOX2 and CDX2 Expression in Barrett’s Mucosa

Rita Barros | Daniela Pereira | ... | Paula Chaves
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 3825819
  • - Review Article

Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis

Changqing Yin | Changliang Luo | ... | Fubing Wang
  • Disease Markers -
  • Special Issue
  • Volume 2016
  • - Article ID 4801418
  • - Review Article

Cytokine Profile in Chronic Periodontitis Patients with and without Obesity: A Systematic Review and Meta-Analysis

Zohaib Akram | Tariq Abduljabbar | ... | Fahim Vohra

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.